Global Adult Malignant Glioma Treatment Industry Research & Trends Analysis Report
According to Latest Study, the global market for Adult Malignant Glioma Treatment should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Adult Malignant Glioma Treatment market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Adult Malignant Glioma Treatment market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Chemotherapy segment holds a share about % in 2024 and will reach % in 2030; while in terms of application, Glioblastoma Multiforme has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Adult Malignant Glioma Treatment include Merck & Co., Inc, F. Hoffmann-La Roche Ltd, Arbor Pharmaceuticals, Pfizer,Inc, AbbVie, Inc, Amgen, Inc, Bristol-Myers Squibb Company, Sun Pharmaceuticals Ltd and Teva Pharmaceutical Industries Limited, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Malignant gliomas, tumors derived from the neuroepithelium are collectively referred to as gliomas (gliomas), accounting for 40-50% of brain tumors, and are the most common intracranial malignant tumors. According to pathology, it can be divided into astrocytoma, medulloblastoma, glioblastoma multiforme, ependymoma, oligodendroglioma and so on.
This report aims to provide a comprehensive study of the global market for Adult Malignant Glioma Treatment. Report Highlights:
(1) Global Adult Malignant Glioma Treatment market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2024 to 2030.
(2) Global Adult Malignant Glioma Treatment market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(3) China Adult Malignant Glioma Treatment market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(4) Global Adult Malignant Glioma Treatment segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Adult Malignant Glioma Treatment segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Adult Malignant Glioma Treatment, capacity, production and trends.
(7) Adult Malignant Glioma Treatment industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Chemotherapy
Targeted Drug Therapy
Market segment by application, can be divided into
Glioblastoma Multiforme
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma
Anaplastic Oligoastrocytoma
Other
Market segment by players, this report covers
Merck & Co., Inc
F. Hoffmann-La Roche Ltd
Arbor Pharmaceuticals
Pfizer,Inc
AbbVie, Inc
Amgen, Inc
Bristol-Myers Squibb Company
Sun Pharmaceuticals Ltd
Teva Pharmaceutical Industries Limited
Emcure Pharmaceuticals Limited
Bayer
SL Pharm
Boan Biotech
1 Market Overview
1.1 Adult Malignant Glioma Treatment Definition
1.2 Global Adult Malignant Glioma Treatment Market Size and Forecast
1.2.1 By Revenue, Global Adult Malignant Glioma Treatment Market Size, 2019-2030
1.2.2 By Sales Volume, Global Adult Malignant Glioma Treatment Market Size, 2019-2030
1.2.3 Global Adult Malignant Glioma Treatment Price Trend, 2019-2030
1.3 China Adult Malignant Glioma Treatment Market Size and Forecast
1.3.1 By Revenue, China Adult Malignant Glioma Treatment Market Size, 2019-2030
1.3.2 By Sales Volume, China Adult Malignant Glioma Treatment Market Size, 2019-2030
1.3.3 China Adult Malignant Glioma Treatment Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Adult Malignant Glioma Treatment Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Adult Malignant Glioma Treatment Share in Global Market, 2019-2030
1.4.3 Adult Malignant Glioma Treatment Market Size: China VS Global, 2019-2030
1.5 Adult Malignant Glioma Treatment Market Dynamics
1.5.1 Adult Malignant Glioma Treatment Market Drivers
1.5.2 Adult Malignant Glioma Treatment Market Restraints
1.5.3 Adult Malignant Glioma Treatment Industry Trends
1.5.4 Adult Malignant Glioma Treatment Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Adult Malignant Glioma Treatment Revenue by Company, 2019-2024
2.2 Global Adult Malignant Glioma Treatment Sales Volume by Company, 2019-2024
2.3 Global Adult Malignant Glioma Treatment Price by Company, 2019-2024
2.4 Global Adult Malignant Glioma Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Adult Malignant Glioma Treatment Concentration Ratio
2.6 Global Adult Malignant Glioma Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Adult Malignant Glioma Treatment Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Adult Malignant Glioma Treatment Revenue by Company, 2019-2024
3.2 China Adult Malignant Glioma Treatment Sales Volume by Company, 2019-2024
3.3 China Adult Malignant Glioma Treatment Adult Malignant Glioma Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Adult Malignant Glioma Treatment Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Adult Malignant Glioma Treatment Domestic VS Export
3.6 China Market, Adult Malignant Glioma Treatment Import & Export
3.6.1 China Market, Adult Malignant Glioma Treatment Import & Export, 2019-2030
3.6.2 China Adult Malignant Glioma Treatment Import & Export Trends
3.6.3 Main Sources of China Adult Malignant Glioma Treatment Import
3.6.4 Export Destination of China Adult Malignant Glioma Treatment
4 Adult Malignant Glioma Treatment Production by Region
4.1 Global Adult Malignant Glioma Treatment Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Adult Malignant Glioma Treatment Manufacturers
4.3 Global Major Manufacturers, Adult Malignant Glioma Treatment Capacity Expansion and Future Plans
4.4 Global Adult Malignant Glioma Treatment Capacity by Region
4.5 Global Adult Malignant Glioma Treatment Production by Region
4.5.1 Global Adult Malignant Glioma Treatment Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Adult Malignant Glioma Treatment Production by Region, 2019-2024
4.5.3 Global Adult Malignant Glioma Treatment Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Adult Malignant Glioma Treatment Industry Chain
5.2 Adult Malignant Glioma Treatment Upstream Analysis
5.2.1 Adult Malignant Glioma Treatment Core Raw Materials
5.2.2 Main Manufacturers of Adult Malignant Glioma Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Adult Malignant Glioma Treatment Production Mode
5.6 Adult Malignant Glioma Treatment Procurement Model
5.7 Adult Malignant Glioma Treatment Industry Sales Model and Sales Channels
5.7.1 Adult Malignant Glioma Treatment Sales Model
5.7.2 Adult Malignant Glioma Treatment Typical Distributors
6 Sights by Type
6.1 Adult Malignant Glioma Treatment Classification
6.1.1 Chemotherapy
6.1.2 Targeted Drug Therapy
6.2 By Type, Global Adult Malignant Glioma Treatment Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Adult Malignant Glioma Treatment Revenue, 2019-2030
6.4 By Type, Global Adult Malignant Glioma Treatment Sales Volume, 2019-2030
6.5 By Type, Global Adult Malignant Glioma Treatment Price, 2019-2030
7 Sights by Application
7.1 Adult Malignant Glioma Treatment Segment by Application
7.1.1 Glioblastoma Multiforme
7.1.2 Anaplastic Astrocytoma
7.1.3 Anaplastic Oligodendroglioma
7.1.4 Anaplastic Oligoastrocytoma
7.1.5 Other
7.2 By Application, Global Adult Malignant Glioma Treatment Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Adult Malignant Glioma Treatment Revenue, 2019-2030
7.4 By Application, Global Adult Malignant Glioma Treatment Sales Volume, 2019-2030
7.5 By Application, Global Adult Malignant Glioma Treatment Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Adult Malignant Glioma Treatment Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Adult Malignant Glioma Treatment Revenue, 2019-2030
8.3 By Region, Global Adult Malignant Glioma Treatment Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Adult Malignant Glioma Treatment Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Adult Malignant Glioma Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Adult Malignant Glioma Treatment Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Adult Malignant Glioma Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Adult Malignant Glioma Treatment Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Adult Malignant Glioma Treatment Market Size Market Share
8.7 South America
8.7.1 South America Adult Malignant Glioma Treatment Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Adult Malignant Glioma Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Adult Malignant Glioma Treatment Market Size & CAGR，2019 VS 2024 VS 2030
9.2 By Country, Global Adult Malignant Glioma Treatment Revenue, 2019-2030
9.3 By Country, Global Adult Malignant Glioma Treatment Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Adult Malignant Glioma Treatment Market Size, 2019-2030
9.4.2 By Company, U.S. Adult Malignant Glioma Treatment Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Adult Malignant Glioma Treatment Market Size, 2019-2030
9.5.2 By Company, Europe Adult Malignant Glioma Treatment Sales Volume Market Share, 2022
9.5.3 By Type, Europe Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Adult Malignant Glioma Treatment Market Size, 2019-2030
9.6.2 By Company, China Adult Malignant Glioma Treatment Sales Volume Market Share, 2022
9.6.3 By Type, China Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Adult Malignant Glioma Treatment Market Size, 2019-2030
9.7.2 By Company, Japan Adult Malignant Glioma Treatment Sales Volume Market Share, 2022
9.7.3 By Type, Japan Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Adult Malignant Glioma Treatment Market Size, 2019-2030
9.8.2 By Company, South Korea Adult Malignant Glioma Treatment Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Adult Malignant Glioma Treatment Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Adult Malignant Glioma Treatment Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Adult Malignant Glioma Treatment Market Size, 2019-2030
9.10.2 By Company, India Adult Malignant Glioma Treatment Sales Volume Market Share, 2022
9.10.3 By Type, India Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Adult Malignant Glioma Treatment Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Adult Malignant Glioma Treatment Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Adult Malignant Glioma Treatment Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Merck & Co., Inc
10.1.1 Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
10.1.2 Merck & Co., Inc Adult Malignant Glioma Treatment Models, Specifications and Application
10.1.3 Merck & Co., Inc Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Merck & Co., Inc Company Profile and Main Business
10.1.5 Merck & Co., Inc Recent Developments
10.2 F. Hoffmann-La Roche Ltd
10.2.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.2.2 F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Models, Specifications and Application
10.2.3 F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.2.5 F. Hoffmann-La Roche Ltd Recent Developments
10.3 Arbor Pharmaceuticals
10.3.1 Arbor Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.3.2 Arbor Pharmaceuticals Adult Malignant Glioma Treatment Models, Specifications and Application
10.3.3 Arbor Pharmaceuticals Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Arbor Pharmaceuticals Company Profile and Main Business
10.3.5 Arbor Pharmaceuticals Recent Developments
10.4 Pfizer,Inc
10.4.1 Pfizer,Inc Company Information, Head Office, Market Area and Industry Position
10.4.2 Pfizer,Inc Adult Malignant Glioma Treatment Models, Specifications and Application
10.4.3 Pfizer,Inc Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Pfizer,Inc Company Profile and Main Business
10.4.5 Pfizer,Inc Recent Developments
10.5 AbbVie, Inc
10.5.1 AbbVie, Inc Company Information, Head Office, Market Area and Industry Position
10.5.2 AbbVie, Inc Adult Malignant Glioma Treatment Models, Specifications and Application
10.5.3 AbbVie, Inc Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 AbbVie, Inc Company Profile and Main Business
10.5.5 AbbVie, Inc Recent Developments
10.6 Amgen, Inc
10.6.1 Amgen, Inc Company Information, Head Office, Market Area and Industry Position
10.6.2 Amgen, Inc Adult Malignant Glioma Treatment Models, Specifications and Application
10.6.3 Amgen, Inc Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Amgen, Inc Company Profile and Main Business
10.6.5 Amgen, Inc Recent Developments
10.7 Bristol-Myers Squibb Company
10.7.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
10.7.2 Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Models, Specifications and Application
10.7.3 Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.7.5 Bristol-Myers Squibb Company Recent Developments
10.8 Sun Pharmaceuticals Ltd
10.8.1 Sun Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position
10.8.2 Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Models, Specifications and Application
10.8.3 Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Sun Pharmaceuticals Ltd Company Profile and Main Business
10.8.5 Sun Pharmaceuticals Ltd Recent Developments
10.9 Teva Pharmaceutical Industries Limited
10.9.1 Teva Pharmaceutical Industries Limited Company Information, Head Office, Market Area and Industry Position
10.9.2 Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Models, Specifications and Application
10.9.3 Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Teva Pharmaceutical Industries Limited Company Profile and Main Business
10.9.5 Teva Pharmaceutical Industries Limited Recent Developments
10.10 Emcure Pharmaceuticals Limited
10.10.1 Emcure Pharmaceuticals Limited Company Information, Head Office, Market Area and Industry Position
10.10.2 Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Models, Specifications and Application
10.10.3 Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Emcure Pharmaceuticals Limited Company Profile and Main Business
10.10.5 Emcure Pharmaceuticals Limited Recent Developments
10.11 Bayer
10.11.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.11.2 Bayer Adult Malignant Glioma Treatment Models, Specifications and Application
10.11.3 Bayer Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Bayer Company Profile and Main Business
10.11.5 Bayer Recent Developments
10.12 SL Pharm
10.12.1 SL Pharm Company Information, Head Office, Market Area and Industry Position
10.12.2 SL Pharm Adult Malignant Glioma Treatment Models, Specifications and Application
10.12.3 SL Pharm Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 SL Pharm Company Profile and Main Business
10.12.5 SL Pharm Recent Developments
10.13 Boan Biotech
10.13.1 Boan Biotech Company Information, Head Office, Market Area and Industry Position
10.13.2 Boan Biotech Adult Malignant Glioma Treatment Models, Specifications and Application
10.13.3 Boan Biotech Adult Malignant Glioma Treatment Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Boan Biotech Company Profile and Main Business
10.13.5 Boan Biotech Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Adult Malignant Glioma Treatment Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Adult Malignant Glioma Treatment Market Restraints
Table 3. Adult Malignant Glioma Treatment Market Trends
Table 4. Adult Malignant Glioma Treatment Industry Policy
Table 5. Global Adult Malignant Glioma Treatment Revenue by Company, 2019-2024, US$ million
Table 6. Global Adult Malignant Glioma Treatment Revenue Market Share by Company, 2019-2024
Table 7. Global Adult Malignant Glioma Treatment Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Adult Malignant Glioma Treatment Sales Volume Market Share by Company, 2019-2024
Table 9. Global Adult Malignant Glioma Treatment Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Adult Malignant Glioma Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Adult Malignant Glioma Treatment Mergers & Acquisitions, Expansion Plans
Table 12. Global Adult Malignant Glioma Treatment Manufacturers Product Type
Table 13. China Adult Malignant Glioma Treatment Revenue by Company, 2019-2024, US$ million
Table 14. China Adult Malignant Glioma Treatment Revenue Market Share by Company, 2019-2024
Table 15. China Adult Malignant Glioma Treatment Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Adult Malignant Glioma Treatment Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Adult Malignant Glioma Treatment Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Adult Malignant Glioma Treatment Import & Export Trends
Table 19. Main Sources of China Adult Malignant Glioma Treatment Import
Table 20. Export Destination of China Adult Malignant Glioma Treatment
Table 21. Global Headquarters and Manufacturing Base of Adult Malignant Glioma Treatment Manufacturers
Table 22. Global Major Manufacturers, Adult Malignant Glioma Treatment Capacity Expansion and Future Plans
Table 23. Global Adult Malignant Glioma Treatment Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Adult Malignant Glioma Treatment Production by Region, 2019-2024, (K Units)
Table 25. Global Adult Malignant Glioma Treatment Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Adult Malignant Glioma Treatment Upstream (Raw Materials)
Table 27. Global Adult Malignant Glioma Treatment Typical Customers
Table 28. Adult Malignant Glioma Treatment Typical Distributors
Table 29. By Type, Global Adult Malignant Glioma Treatment Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Adult Malignant Glioma Treatment Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Adult Malignant Glioma Treatment Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Adult Malignant Glioma Treatment Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Adult Malignant Glioma Treatment Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Adult Malignant Glioma Treatment Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Adult Malignant Glioma Treatment Revenue Market Share, 2019-2030
Table 37. By Country, Global Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Adult Malignant Glioma Treatment Sales Volume Market Share, 2019-2030
Table 39. Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
Table 40. Merck & Co., Inc Adult Malignant Glioma Treatment Models, Specifications and Application
Table 41. Merck & Co., Inc Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Merck & Co., Inc Company Profile and Main Business
Table 43. Merck & Co., Inc Recent Developments
Table 44. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 45. F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Models, Specifications and Application
Table 46. F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 48. F. Hoffmann-La Roche Ltd Recent Developments
Table 49. Arbor Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 50. Arbor Pharmaceuticals Adult Malignant Glioma Treatment Models, Specifications and Application
Table 51. Arbor Pharmaceuticals Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Arbor Pharmaceuticals Company Profile and Main Business
Table 53. Arbor Pharmaceuticals Recent Developments
Table 54. Pfizer,Inc Company Information, Head Office, Market Area and Industry Position
Table 55. Pfizer,Inc Adult Malignant Glioma Treatment Models, Specifications and Application
Table 56. Pfizer,Inc Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Pfizer,Inc Company Profile and Main Business
Table 58. Pfizer,Inc Recent Developments
Table 59. AbbVie, Inc Company Information, Head Office, Market Area and Industry Position
Table 60. AbbVie, Inc Adult Malignant Glioma Treatment Models, Specifications and Application
Table 61. AbbVie, Inc Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. AbbVie, Inc Company Profile and Main Business
Table 63. AbbVie, Inc Recent Developments
Table 64. Amgen, Inc Company Information, Head Office, Market Area and Industry Position
Table 65. Amgen, Inc Adult Malignant Glioma Treatment Models, Specifications and Application
Table 66. Amgen, Inc Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Amgen, Inc Company Profile and Main Business
Table 68. Amgen, Inc Recent Developments
Table 69. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
Table 70. Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Models, Specifications and Application
Table 71. Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Bristol-Myers Squibb Company Company Profile and Main Business
Table 73. Bristol-Myers Squibb Company Recent Developments
Table 74. Sun Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position
Table 75. Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Models, Specifications and Application
Table 76. Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Sun Pharmaceuticals Ltd Company Profile and Main Business
Table 78. Sun Pharmaceuticals Ltd Recent Developments
Table 79. Teva Pharmaceutical Industries Limited Company Information, Head Office, Market Area and Industry Position
Table 80. Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Models, Specifications and Application
Table 81. Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Teva Pharmaceutical Industries Limited Company Profile and Main Business
Table 83. Teva Pharmaceutical Industries Limited Recent Developments
Table 84. Emcure Pharmaceuticals Limited Company Information, Head Office, Market Area and Industry Position
Table 85. Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Models, Specifications and Application
Table 86. Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Emcure Pharmaceuticals Limited Company Profile and Main Business
Table 88. Emcure Pharmaceuticals Limited Recent Developments
Table 89. Bayer Company Information, Head Office, Market Area and Industry Position
Table 90. Bayer Adult Malignant Glioma Treatment Models, Specifications and Application
Table 91. Bayer Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Bayer Company Profile and Main Business
Table 93. Bayer Recent Developments
Table 94. SL Pharm Company Information, Head Office, Market Area and Industry Position
Table 95. SL Pharm Adult Malignant Glioma Treatment Models, Specifications and Application
Table 96. SL Pharm Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. SL Pharm Company Profile and Main Business
Table 98. SL Pharm Recent Developments
Table 99. Boan Biotech Company Information, Head Office, Market Area and Industry Position
Table 100. Boan Biotech Adult Malignant Glioma Treatment Models, Specifications and Application
Table 101. Boan Biotech Adult Malignant Glioma Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. Boan Biotech Company Profile and Main Business
Table 103. Boan Biotech Recent Developments
List of Figure
Figure 1. Adult Malignant Glioma Treatment Picture
Figure 2. By Revenue, Global Adult Malignant Glioma Treatment Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Adult Malignant Glioma Treatment Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Adult Malignant Glioma Treatment Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Adult Malignant Glioma Treatment Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Adult Malignant Glioma Treatment Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Adult Malignant Glioma Treatment Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Adult Malignant Glioma Treatment Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Adult Malignant Glioma Treatment Share of Global Market, 2019-2030
Figure 10. Global Adult Malignant Glioma Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Adult Malignant Glioma Treatment Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Adult Malignant Glioma Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Adult Malignant Glioma Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Adult Malignant Glioma Treatment Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Adult Malignant Glioma Treatment Domestic VS Export, 2022
Figure 16. Global Adult Malignant Glioma Treatment Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Adult Malignant Glioma Treatment Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Adult Malignant Glioma Treatment Production Market Share & Forecast by Region, 2019-2030
Figure 19. Adult Malignant Glioma Treatment Industry Chain
Figure 20. Adult Malignant Glioma Treatment Procurement Model
Figure 21. Adult Malignant Glioma Treatment Sales Model
Figure 22. Adult Malignant Glioma Treatment Sales Channels, Direct Sales and Distribution
Figure 23. Chemotherapy
Figure 24. Targeted Drug Therapy
Figure 25. By Type, Global Adult Malignant Glioma Treatment Revenue, 2019-2030, US$ Million
Figure 26. By Type, Global Adult Malignant Glioma Treatment Revenue Market Share, 2019-2030
Figure 27. By Type, Global Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Figure 28. By Type, Global Adult Malignant Glioma Treatment Sales Volume Market Share, 2019-2030
Figure 29. By Type, Global Adult Malignant Glioma Treatment Price, 2019-2030, (US$/Unit)
Figure 30. Glioblastoma Multiforme
Figure 31. Anaplastic Astrocytoma
Figure 32. Anaplastic Oligodendroglioma
Figure 33. Anaplastic Oligoastrocytoma
Figure 34. Other
Figure 35. By Application, Global Adult Malignant Glioma Treatment Revenue, 2019-2030, US$ Million
Figure 36. By Application, Global Adult Malignant Glioma Treatment Revenue Market Share, 2019-2030
Figure 37. By Application, Global Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Figure 38. By Application, Global Adult Malignant Glioma Treatment Sales Volume Market Share, 2019-2030
Figure 39. By Application, Global Adult Malignant Glioma Treatment Price, 2019-2030, (US$/Unit)
Figure 40. By Region, Global Adult Malignant Glioma Treatment Revenue Market Share, 2019-2030
Figure 41. By Region, Global Adult Malignant Glioma Treatment Sales Volume Market Share, 2019-2030
Figure 42. North America Adult Malignant Glioma Treatment Revenue & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, North America Adult Malignant Glioma Treatment Revenue Market Share, 2022
Figure 44. Europe Adult Malignant Glioma Treatment Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country, Europe Adult Malignant Glioma Treatment Revenue Market Share, 2022
Figure 46. Asia Pacific Adult Malignant Glioma Treatment Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country/Region, Asia Pacific Adult Malignant Glioma Treatment Revenue Market Share, 2022
Figure 48. South America Adult Malignant Glioma Treatment Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. By Country, South America Adult Malignant Glioma Treatment Revenue Market Share, 2022
Figure 50. Middle East & Africa Adult Malignant Glioma Treatment Revenue & Forecasts, 2019-2030, US$ Million
Figure 51. U.S. Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Figure 52. By Company, U.S. Adult Malignant Glioma Treatment Market Share, 2022
Figure 53. By Type, U.S. Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Figure 56. By Company, Europe Adult Malignant Glioma Treatment Market Share, 2022
Figure 57. By Type, Europe Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 59. China Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Figure 60. By Company, China Adult Malignant Glioma Treatment Market Share, 2022
Figure 61. By Type, China Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Figure 64. By Company, Japan Adult Malignant Glioma Treatment Market Share, 2022
Figure 65. By Type, Japan Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Figure 68. By Company, South Korea Adult Malignant Glioma Treatment Market Share, 2022
Figure 69. By Type, South Korea Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, South Korea Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 71. Southeast Asia Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Figure 72. By Company, Southeast Asia Adult Malignant Glioma Treatment Market Share, 2022
Figure 73. By Type, Southeast Asia Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, Southeast Asia Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 75. India Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Figure 76. By Company, India Adult Malignant Glioma Treatment Market Share, 2022
Figure 77. By Type, India Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, India Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 79. Middle East & Asia Adult Malignant Glioma Treatment Sales Volume, 2019-2030, (K Units)
Figure 80. By Company, Middle East & Asia Adult Malignant Glioma Treatment Market Share, 2022
Figure 81. By Type, Middle East & Asia Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, Middle East & Asia Adult Malignant Glioma Treatment Sales Volume Market Share, 2022 VS 2029
Figure 83. Research Methodology
Figure 84. Breakdown of Primary Interviews
Figure 85. Bottom-up Approaches
Figure 86. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|